Navigation Links
FDA Approves Low-dose Regimen of PREMARIN Vaginal Cream to Treat Moderate to Severe Postmenopausal Dyspareunia - Painful Sexual Intercourse
Date:11/13/2008

Agency Grants New Indication for Bothersome Vaginal Symptom Associated With Menopause

COLLEGEVILLE, Pa., Nov. 13 /PRNewswire-FirstCall/ -- PREMARIN(R) (conjugated estrogens) Vaginal Cream 0.5 g has been approved by the U.S. Food and Drug Administration (FDA) for a new indication and a new less frequent twice-weekly dosing regimen to treat moderate to severe postmenopausal dyspareunia (painful sexual intercourse) announced Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE).

"This approval is welcome news, especially when you consider that more than one in four untreated postmenopausal women experience dyspareunia, a symptom of vulvar and vaginal atrophy, which typically does not subside without treatment," says Gloria Bachmann, M.D., Director of the Women's Health Institute at the University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, New Brunswick, N.J. and Chief of the OB/GYN service at the teaching hospital.

PREMARIN Vaginal Cream is the first vaginal estrogen therapy indicated for the treatment of moderate to severe dyspareunia due to menopause. A low-volume regimen of PREMARIN Vaginal Cream can treat painful intercourse due to menopause, restore vaginal tissue, and reverse changes in the vagina that occur with menopause.

The approval is based on efficacy results from a multicenter clinical study that included a 12-week randomized, double-blind placebo phase followed by a 40-week open-label phase. Results from the 12-week phase showed that both low-dose regimens of PREMARIN Vaginal Cream (0.5 g daily [21 days on/7 days off] or twice weekly) significantly improved the dyspareunia score versus placebo at 12 weeks. In this study, dyspareunia was one of the most bothersome symp
'/>"/>

SOURCE Wyeth Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. FDA Approves First Anti-Psychotic for Kids
2. FDA Approves New Roche West Nile Virus Blood Screening Test
3. FDA Approves Osteoporosis Drug to Cut Breast Cancer Risk
4. FDA Approves LEVAQUIN(R) Short-Course Therapy for Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis
5. FDA Approves SOMA(R) (carisoprodol) 250 mg
6. FDA Approves Expanded Label for FluMist(R) to Include Children Two to Five Years of Age
7. FDA approves expanded label for FluMist (influenza virus vaccine live, intranasal) to include childr
8. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
9. ABIH Approves Certification Credit for SSPC Training Courses
10. FDA Approves REALIZE(TM) Adjustable Gastric Band for Morbid Obesity
11. FDA Approves New Flu Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... United States Vice President Dick Cheney served as the ... , In front of 1,500 guests yesterday at ... "I am delighted to be here to have the ... Year Award. I think it's a tremendous recognition; I ... company like this because there are obviously a great ...
(Date:5/23/2013)... 23, 2013 Jeanne Ettelson, president of ... its popular and only free OCD support group in ... resource for OCD sufferers, the group is lead by ... disorders. This allows group participants to learn accurate ... Response Prevention. , “Participants in Beyond OCD’s support ...
(Date:5/23/2013)... News) -- The sensation of itching is hardwired into ... a small molecule released in the spinal cord, according ... say this molecule, known as natriuretic polypeptide b (Nppb), ... system. Ultimately, this signal is experienced as an itch. ... similar, the researchers concluded that a similar process probably ...
(Date:5/23/2013)... May 23 (HealthDay News) -- Although a study ... the thinking and memory problems associated with Alzheimer,s ... have been unable to duplicate those findings. ... implications for patient safety since the drug involved ... effects, such as major blood-lipid abnormalities, pancreatitis, headaches, ...
(Date:5/23/2013)... Netsmart today announced it is ranked #49 ... technology (HIT) providers for 2013. , The HCI 100 listing ... Informatics magazine. Netsmart’s ranking of #49 is up from ... is largely due to our commitment to helping organizations forge ... resources are scarce, the demand for care is unprecedented and ...
Breaking Medicine News(10 mins):Health News:Acadian Ambulance Honors Paramedic of the Year at Annual Luncheon 2Health News:Beyond OCD Support Group Marks Fifth Anniversary 2Health News:Got an Itch? Mouse Study May Help Explain Why 2Health News:Scientists Can't Replicate Surprising Finding on Alzheimer's Treatment 2Health News:Netsmart Named to Healthcare Informatics Top 100 List 2
... already collaborating on several projects, including the mapping of ... bacteria, compiled from 577 billion base pairs of sequence ... this work as one of the scientific breakthroughs of ... in life sciences, healthcare and agricultural research. Henry ...
... In their search for new, better ways to diagnose ... discovered that measurement of C-reactive protein in the synovial ... white blood cell count (WBC) and the percentage of ... minimal role in the determination of PJI. , The ...
... HealthDay Reporter , MONDAY, Feb. 6 (HealthDay News) -- ... diabetes, the first line of defense is lifestyle changes such ... those lifestyle changes don,t get blood sugar levels under control, ... as the first oral treatment that should be given. ...
... have, for the first time, described the genetic basis of ... by chronic pelvic pain and infertility. The researchers, discovery of ... Published in the Feb. 3 early online issue of ... mutation located in part of the KRAS gene, which leads ...
... HealthDay Reporter , MONDAY, Feb. 6 (HealthDay News) -- ... in cars, more than 20 percent of nonsmoking teens still ... particularly intense in a closed space, such as inside a ... "There have been marked decreases in exposure to smoking ...
... , MONDAY, Feb. 6 (HealthDay News) -- ... processing information in men, but not in women, new research ... more reason to quit the habit. "This study underscores ... smoking is a modifiable risk factor with an effect size ...
Cached Medicine News:Health News:VIB and BGI organize joint genomics meeting, Feb. 15, 2012, Belgium 2Health News:VIB and BGI organize joint genomics meeting, Feb. 15, 2012, Belgium 3Health News:Metformin Preferred Drug for Type 2 Diabetes, Experts Say 2Health News:Metformin Preferred Drug for Type 2 Diabetes, Experts Say 3Health News:Gene mutation discovery sparks hope for effective endometriosis screening 2Health News:Fewer Teens Exposed to Tobacco Smoke in Cars: Report 2Health News:Fewer Teens Exposed to Tobacco Smoke in Cars: Report 3Health News:Smoking May Be Especially Tough on Men's Brains 2
(Date:5/23/2013)... May 23, 2013 SynCardia Systems, Inc. ( ... FDA, Health Canada and CE ( Europe ... Glasgow Science Centre in Scotland , ... the SynCardia temporary Total Artificial Heart powered ... $3 million Bodyworks Exhibition, one of the most advanced ...
(Date:5/23/2013)... May 23, 2013 InspireMD, ... the leader in embolic protection stents, today announced ... Acute ST Elevation Reperfusion) trial demonstrating that the ... and drug eluting stents in all-cause mortality in ... from the trial were presented at the InspireMD ...
(Date:5/23/2013)... 2013  PAREXEL International Corporation (NASDAQ: PRXL ... the Jefferies Healthcare Conference in New York.  ... Financial Officer, will be making a presentation on PAREXEL ... June 3, 2013. A live webcast of ... of PAREXEL,s website at www.PAREXEL.com in the ...
Breaking Medicine Technology:Glasgow Science Centre Features SynCardia Total Artificial Heart in $3 Million Exhibition 2Glasgow Science Centre Features SynCardia Total Artificial Heart in $3 Million Exhibition 3InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 2InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 3InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 4InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 5PAREXEL International To Present At Jefferies Healthcare Conference 2
... , , , , ... a Bay(R) Pharmaceuticals , Inc. (NYSE-Amex: NBY ... treatment or prevention of a wide range of bacterial, viral, and ... Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco, ...
... , , , ... (Nasdaq: WHRT ) - World Heart Corporation (WorldHeart) announced today ... of the Levacor Ventricular Assist Device (VAD) at ten US centers. ... information to the FDA within 45 days, but the study is permitted to ...
Cached Medicine Technology:NovaBay Pharmaceuticals to Present New Data on Lead Anti-Infective Compound at the 2009 ICAAC Annual Meeting 2NovaBay Pharmaceuticals to Present New Data on Lead Anti-Infective Compound at the 2009 ICAAC Annual Meeting 3WorldHeart Receives US Clinical Study Approval for the Levacor(TM) VAD 2WorldHeart Receives US Clinical Study Approval for the Levacor(TM) VAD 3
... When Welch Allyn designed the ... in 1915, they began a tradition ... eye care professionals worldwide. In keeping ... introduces the prestigious 3.5v Coaxial-plus Ophthalmoscope. ...
Welch Allyn quality in a convenient pocket size. The PocketScope fits into your pocket! Easy to use, lightweight, and perfect for general and specialist use. Take your PocketScope with you everywhere...
... ALE-3600 and ALE-3600PC Patternless ... fit lenses to frames, ... the convenience of complete ... edgers are particularly suited ...
... the features of the FR-20 Frame Reader with ... no longer need to connect the frame reader ... capable of receiving data via a cable from ... to streamline your edging operations. It stores the ...
Medicine Products: